David Viskochil
Program Director, Medical Genetics & Genomics Residency · Univ of Utah Sch of Med
Credentials: · · · · ·
History
PresentMedical Genetics & Genomics Residency · Univ of Utah Sch of Med
- Present
- Present
- 1977–1981
Research
Cell · 1990 · 1,011 citations
The neurofibromatosis type 1 gene encodes a protein related to GAP
Cell · 1990 · 989 citations
Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus
Cell · 1990 · First of over 10 authors · 947 citations
50 papers · 3 as a fellow
44 papers
20 papers
17 papers
16 papers
15 papers
12 papers
12 papers
Grants
- 2006–2012
Spinal Abnormalities in Neurofibomatosis Type 1
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $1.6M · Utah State Higher Education System--University of Utah
- 1997–2008
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $318.7K · Utah State Higher Education System--University of Utah
- 1991–1994
Molecular Genetics of Neurofibromatosis Type 1
National Institute of Neurological Disorders and Stroke · K08
Contact PI · $235.3K · Utah State Higher Education System--University of Utah
Clinical trials
- 2017–2022
Vitamin D Supplementation for Adults With Neurofibromatosis Type 1 (NF1)
Principal investigator · Terminated · Phase 2
University of Utah
- 2006–2012
Spinal Abnormalities in Neurofibromatosis Type 1 (NF1)
Principal investigator · Completed
University of Utah
Post-trial Access Program of Idursulfase-IT Along With Elaprase in Children With Hunter Syndrome
Site PI · Available
Takeda